Benzinga | Apr 8, 2021 06:02AM EDT

Aprea Therapeutics on Wednesday Received FDA Orphan Drug Designation for eprenetapopt for Treatment of Acute Myeloid Leukemia

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=797420